Sign in

CIK 0001020214 · Accelerated filer

CERUS CORP

Sign in to watch
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
680262011
Phone
9252886000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 4 Open-market sale SVP Reg. & Quality sold 28,513 shares at an average $5.04 ($143,695)
  4. 4 Open-market sale Chief Legal Officer sold 30,307 shares at an average $5.04 ($152,734)
  5. 4 Open-market sale President and CEO sold 165,021 shares at an average $5.04 ($831,634)
  6. 4 Open-market sale Chief Operating Officer sold 41,734 shares at an average $5.04 ($210,320)
  7. 4 Open-market sale Chief Scientific Officer sold 30,307 shares at $5.04 ($152,735)
  8. 4 Open-market sale Chief Financial Officer sold 32,102 shares at an average $5.04 ($161,780)
  9. 4 Open-market sale Chief Medical Officer sold 30,307 shares at $5.04 ($152,735)
  10. 4 Option exercise Director acquired 5,127 shares (option exercise)
  11. 4 Grant or award SVP Reg. & Quality acquired 45,000 shares (grant or award)
  12. 4 Grant or award Chief Legal Officer acquired 52,500 shares (grant or award)
  13. 4 Grant or award Chief Operating Officer acquired 90,000 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 70,000 shares (grant or award)
  15. 4 Grant or award Chief Scientific Officer acquired 45,000 shares (grant or award)
  16. 4 Grant or award Chief Medical Officer acquired 52,500 shares (grant or award)
  17. 4 Open-market sale President and CEO sold 308,263 shares at an average $5.70 ($1,757,043)
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. SC 13G/A Stake Amended Statement of Ownership

Page 15 of 76 · 1,513 filings